NEW YORK, Aug. 17 (GenomeWeb News) – GE Healthcare said today it has established a Molecular Diagnostics business unit, based in Piscataway, NJ, and has appointed Trevor Hawkins as president of Molecular Diagnostics.
Separately, the Little Chalfont, UK, unit of General Electric said that it has moved research activities of its Discovery Systems business to the GE Global Research Center, in Niskayuna, New York.
These moves come several months after GE’s acquisition of Amersham Bioscience in April, and its reorganization of GE Healthcare.
“Both of these moves underscore the strategic importance of functional biology and molecular diagnostics,” Peter Loescher, President and CEO of GE Healthcare said in a statement. “By transferring Discovery Systems’ Research activities to GE Global Research, we benefit from unparalleled scientific and technological resources. Through the establishment of our Molecular Diagnostics business unit, we will accelerate the accuracy and speed of determining disease predisposition and diagnosis.”